Provided by Tiger Trade Technology Pte. Ltd.

Roundhill GLP-1 & Weight Loss ETF

29.60
+0.31121.06%
Post-market: 29.660.0591+0.20%19:30 EDT
Volume:5K
Turnover:139.63K
Market Cap:55.35M
PE:- -
High:29.66
Open:29.08
Low:29.08
Close:29.29
52wk High:37.15
52wk Low:27.34
Shares:1.87M
Float Shares:1.87M
Volume Ratio:0.44
T/O Rate:0.25%
Dividend:0.41
Dividend Rate:1.39%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Pfizer Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
17 hours ago

U.S. Small Caps Move Upward; Kailera Therapeutics Leads Increases

Dow Jones
·
17 hours ago

Pfizer’s New RSV Vaccine Trial Targets Older Adults, Signaling Long-Term Growth Potential

TIPRANKS
·
21 hours ago

Pfizer’s New Asthma Bet: Tilrekimig Phase 3 Trial Moves Forward

TIPRANKS
·
21 hours ago

Novo Nordisk price target lowered to DKK 296 from DKK 310 at Citi

TIPRANKS
·
21 hours ago

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

Dow Jones
·
22 hours ago

5%, Really? the Stock Market's Sudden High-Yielders.

Dow Jones
·
Yesterday

1 Drugs Could Ease Back and Knee Pain, but Doctors Say There are Risks for Older Adults

Dow Jones
·
Yesterday

BofA Securities Adjusts Pfizer Price Target to $29 From $27, Maintains Neutral Rating

MT Newswires Live
·
Yesterday

BofA Securities Adjusts Eli Lilly Price Target to $1,341 From $1,344, Maintains Buy Rating

MT Newswires Live
·
Yesterday

J.P. Morgan Keeps Their Hold Rating on Pfizer (PFE)

TIPRANKS
·
Yesterday

An AI Transformation That Finally Let Pfizer CEO Albert Bourla Sleep Soundly

Deep News
·
Yesterday

Pfizer Limited Confirms SEBI Compliance on Share Dematerialization for Q3 2026

TIPRANKS
·
Yesterday

Analysts Have Conflicting Sentiments on These Healthcare Companies: Envista Holdings (NVST), Bristol-Myers Squibb (BMY) and Eli Lilly & Co (LLY)

TIPRANKS
·
Yesterday

Eli Lilly announces new TOGETHER-PsO trial data

TIPRANKS
·
Yesterday

Pfizer price target raised to $29 from $27 at BofA

TIPRANKS
·
Yesterday

Lilly Says Phase 3b Together-PsO Data Show Broader Biomarker Shifts with Taltz Plus Zepbound vs Taltz Alone

Reuters
·
Yesterday

Eli Lilly price target lowered to $1,341 from $1,344 at BofA

TIPRANKS
·
Yesterday

Eli Lilly - Taltz and Zepbound Together Show Greater Reductions in Inflammatory Immune Activity

THOMSON REUTERS
·
Yesterday

Eli Lilly: Improvements were Maintained or Further Improved Through Week 52, with Safety Consistent with Known Profile of Each Respective Medicine

THOMSON REUTERS
·
Yesterday